Show simple item record

dc.contributor.authorŠimić, Goran
dc.contributor.authorLeko, Mirjana Babić
dc.contributor.authorWray, Selina
dc.contributor.authorHarrington, Charles R.
dc.contributor.authorDelalle, Ivana
dc.contributor.authorJovanov-Milošević, Nataša
dc.contributor.authorBažadona, Danira
dc.contributor.authorBuée, Luc
dc.contributor.authorSilva, Rohan de
dc.contributor.authorGiovanni, Giuseppe Di
dc.contributor.authorWischik, Claude M.
dc.contributor.authorHof, Patrick R.
dc.date.accessioned2017-04-12T23:29:30Z
dc.date.available2017-04-12T23:29:30Z
dc.date.issued2017-04
dc.identifier.citationŠimić , G , Leko , M B , Wray , S , Harrington , C R , Delalle , I , Jovanov-Milošević , N , Bažadona , D , Buée , L , Silva , R D , Giovanni , G D , Wischik , C M & Hof , P R 2017 , ' Monoaminergic Neuropathology in Alzheimer's disease ' Progress in Neurobiology , vol. 151 , pp. 101-138 . https://doi.org/10.1016/j.pneurobio.2016.04.001en
dc.identifier.issn0301-0082
dc.identifier.otherPURE: 66818067
dc.identifier.otherPURE UUID: 8177319c-1ac3-49d6-a970-3681589d2b6a
dc.identifier.otherPubMed: 27084356
dc.identifier.otherScopus: 84971238062
dc.identifier.urihttp://hdl.handle.net/2164/8480
dc.descriptionAcknowledgments This work was supported by The Croatian Science Foundation grant. no. IP-2014-09-9730 (“Tau protein hyperphosphorylation, aggregation, and trans-synaptic transfer in Alzheimer’s disease: cerebrospinal fluid analysis and assessment of potential neuroprotective compounds”) and European Cooperation in Science and Technology (COST) Action CM1103 (“Stucture-based drug design for diagnosis and treatment of neurological diseases: dissecting and modulating complex function in the monoaminergic systems of the brain”). PRH is supported in part by NIH grant P50 AG005138.en
dc.format.extent38en
dc.language.isoeng
dc.relation.ispartofProgress in Neurobiologyen
dc.rights© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subject5-hydroxytryptamine (serotonin)en
dc.subjectAlzheimer's diseaseen
dc.subjectamyloid beta (Aβ) peptideen
dc.subjectblood-brain barrieren
dc.subjectcerebrospinal fluiden
dc.subjectepigeneticsen
dc.subjectlocus coeruleusen
dc.subjectmetalsen
dc.subjectmonoaminesen
dc.subjectneurofibrillary degenerationen
dc.subjectnon-cognitive symptomsen
dc.subjectnucleus raphe dorsalisen
dc.subjectphosphorylationen
dc.subjectsleep-wake cycleen
dc.subjecttau proteinen
dc.subjectRC0321 Neuroscience. Biological psychiatry. Neuropsychiatryen
dc.subject.lccRC0321en
dc.titleMonoaminergic Neuropathology in Alzheimer's diseaseen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen, Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/j.pneurobio.2016.04.001
dc.date.embargoedUntil12-04-20


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record